We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+3.57%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$118M
AUM Growth
+$5.92M
(+5.3%)
Cap. Flow
+$2.18M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
89
New
6
Increased
35
Reduced
24
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFOR
Everforth Inc
EFOR
|
+$232K |
| 2 |
Xylem
XYL
|
+$232K |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$221K |
| 4 |
GAS
AGL Resources Inc
GAS
|
+$209K |
| 5 |
Genuine Parts
GPC
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$169K |
| 2 |
Western Union
WU
|
+$89.5K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$86.9K |
| 4 |
3M
MMM
|
+$75.9K |
| 5 |
State Street
STT
|
+$62.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.03% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 11.34% |
| 4 | Healthcare | 10.79% |
| 5 | Financials | 9.95% |
Similar funds
SCV
TFP
CWM
MG
HWMG
AI
LSWM
IMA
Boston Research & Management's Q3 2013 Portfolio in Review
As of Q3 2013, Boston Research & Management held 89 positions worth $118M, up 5.3% from $112M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Boston Research & Management's Q3 2013 filing shows 6 new, 35 increased and 24 reduced positions. Its largest new stake was Everforth Inc: 7,482 shares worth $246K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $169K.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.
- Boston Research & Management's largest Q3 2013 buy was Everforth Inc: 7,482 shares worth $246K.
- Boston Research & Management added most to Xylem in Q3 2013, an estimated $232K increase.
- Boston Research & Management's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $169K.
- Boston Research & Management's ten largest holdings make up 23% of its $118M portfolio in Q3 2013.
- Boston Research & Management opened 6 new positions and closed 0 in Q3 2013.
- Boston Research & Management's portfolio value rose 5.3% quarter-over-quarter to $118M.
Based on Boston Research & Management's 13F filing for Q3 2013, filed 8 Nov 2013.